TrialClinical pharmacokinetics2025

Pharmacokinetics and Pharmacodynamics of Prusogliptin (DBPR108), a Once-Daily Dipeptidyl Peptidase-4 Inhibitor, in Patients with Type 2 Diabetes.

Wenfang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.